Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis

Frontiers in Oncology

Volumn 12, Issue , 2022, Pages

  Wang, Zheng ^a   Li, Saixin ^a   Jia, Yitong ^a   Liu, Miao ^a   Yang, Kun ^a   Sui, Minghao ^a   Liu, Dongbin ^a   Liang, Kuo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

hepatocellular carcinoma; intraoperative blood salvage autotransfusion; leukocyte depletion filters; liver transplantation; meta analysis; treatment outcome

Indexed keywords

BLOOD AUTOTRANSFUSION; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; META ANALYSIS; NEWCASTLE-OTTAWA SCALE; OVERALL SURVIVAL; PUBLICATION BIAS; QUALITY CONTROL; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 85140973804     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2022.985281     Document Type: Review

References (51)

1. Sugawara Y Hibi T. Surgical treatment of hepatocellular carcinoma. Biosci Trends (2021) 15(3):138–41. doi: 10.5582/bst.2021.01094
2. European Association For The Study Of The LiverEuropean Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 56(4):908–43. doi: 10.1016/j.jhep.2011.12.001
3. Wiesner RH Freeman RB Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology (2004) 127:S261–7. doi: 10.1053/j.gastro.2004.09.040
4. Cleland S Corredor C Ye JJ Srinivas C McCluskey SA. Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant (2016) 6(2):291–305. doi: 10.5500/wjt.v6.i2.291
5. Feltracco P Brezzi M Barbieri S Galligioni H Milevoj M Carollo C et al. Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol (2013) 5(1):1–15. doi: 10.4254/wjh.v5.i1.1
6. Liu L Wang Z Jiang S Shao B Liu J Zhang S et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PloS One (2013) 8(5):e64261. doi: 10.1371/journal.pone.0064261
7. Feltracco P Michieletto E Barbieri S Serra E Rizzi S Salvaterra F et al. Microbiologic contamination of intraoperative blood salvaged during liver transplantation. Transplant Proc (2007) 39(6):1889–91. doi: 10.1016/j.transproceed.2007.05.005
8. Gong Y Tang Y Xue Y Chen L. Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma. Med (Baltimore) (2020) 99(41):e22568. doi: 10.1097/MD.0000000000022568
9. Hill GE Frawley WH Griffith KE Forestner JE Minei JP. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma (2003) 54(5):908–14. doi: 10.1097/01.TA.0000022460.21283.53
10. Elmalky M Yasin N Rodrigues-Pinto R Stephenson J Carroll C Smurthwaite G et al. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. Spine J (2017) 17(7):977–82. doi: 10.1016/j.spinee.2017.03.004
11. DeAndrade D Waters JH Triulzi DJ Alarcon L Wisniewski MK Dyga R et al. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion (2016) 56(11):2768–72. doi: 10.1111/trf.13791
12. Fahrner R Dondorf F Ardelt M Dittmar Y Settmacher U Rauchfuß F. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. World J Gastroenterol (2015) 21(42):12071–82. doi: 10.3748/wjg.v21.i42.12071
13. Trudeau JD Waters T Chipperfield K. Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy? Can J Anaesth (2012) 59(11):1058–70. doi: 10.1007/s12630-012-9781-x
14. Foltys D Zimmermann T Heise M Kaths M Lautem A Wisser G et al. Liver transplantation for hepatocellular carcinoma–is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res (2011) 47(3):182–7. doi: 10.1159/000330746
15. Kozek-Langenecker SA Ahmed AB Afshari A Albaladejo P Aldecoa C Barauskas G et al. Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology: First update 2016. Eur J Anaesthesiol (2017) 34(6):332–95. doi: 10.1097/EJA.0000000000000630
16. Pinto MA Chedid MF Sekine L Schmidt AP Capra RP Prediger C et al. Intraoperative cell salvage with autologous transfusion in liver transplantation. World J Gastrointest Surg (2019) 11(1):11–8. doi: 10.4240/wjgs.v11.i1.11
17. Page MJ McKenzie JE Bossuyt PM Boutron I Hoffmann TC Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev (2021) 10(1):89. doi: 10.1186/s13643-021-01626-4
18. Cumpston M Li T Page MJ Chandler J Welch VA Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev (2019) 10:ED000142. doi: 10.1002/14651858.ED000142
19. Higgins JP Altman DG Gøtzsche PC Jüni P Moher D Oxman AD et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 343:d5928. doi: 10.1136/bmj.d5928
20. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol (2010) 25(9):603–5. doi: 10.1007/s10654-010-9491-z
21. Bruix J Sherman M American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology (2011) 53(3):1020–2. doi: 10.1002/hep.24199
22. Wan X Wang W Liu J Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol (2014) 14:135. doi: 10.1186/1471-2288-14-135
23. Higgins JP Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 21(11):1539–58. doi: 10.1002/sim.1186
24. Egger M Davey Smith G Schneider M Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 315(7109):629–34. doi: 10.1136/bmj.315.7109.629
25. Sterne JA Sutton AJ Ioannidis JP Terrin N Jones DR Lau J et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 343:d4002. doi: 10.1136/bmj.d4002
26. Begg C Cho M Eastwood S Horton R Moher D Olkin I et al. Improving the quality of reporting of randomized controlled trials. the CONSORT statement. JAMA (1996) 276(8):637–9. doi: 10.1001/jama.276.8.637
27. Akbulut S Kayaalp C Yilmaz M Ince V Ozgor D Karabulut K et al. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol (2013) 19(10):1625–31. doi: 10.3748/wjg.v19.i10.1625
28. Araujo RL Pantanali CA Haddad L Rocha Filho JA D'Albuquerque LA Andraus W. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg (2016) 8(2):161–8. doi: 10.4240/wjgs.v8.i2.161
29. Han S Kim G Ko JS Sinn DH Yang JD Joh JW et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg (2016) 264(2):339–43. doi: 10.1097/SLA.0000000000001486
30. Ivanics T Shubert CR Muaddi H Claasen MPAW Yoon P Hansen BE et al. Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: A propensity score-matched analysis. Ann Surg Oncol (2021) 28(11):6816–25. doi: 10.1245/s10434-021-09863-6
31. Kim JM Kim GS Joh JW Suh KS Park JB Ko JS et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int (2013) 26(1):84–9. doi: 10.1111/tri.12001
32. Kwon JH Han S Kim D Kuk JH Cho H Kim S et al. Blood salvage and autotransfusion does not increase the risk of tumor recurrence after liver transplantation for advanced hepatocellular carcinoma. Ann Surg (2021). doi: 10.1097/SLA.0000000000004866
33. Muscari F Suc B Vigouroux D Duffas JP Miqueres I Mathieu A et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int (2005) 18(11):1236–9. doi: 10.1111/j.1432-2277.2005.00207.x
34. Nutu OA Sneiders D Mirza D Isaac J Perera MTPR Hartog H. Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis. Transpl Int (2021) 34(12):2887–94. doi: 10.1111/tri.14150
35. Pinto MA Grezzana-Filho TJM Chedid AD Leipnitz I Prediger JE Alvares-da-Silva MR et al. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg (2021) 406(1):67–74. doi: 10.1007/s00423-020-01997-7
36. Sutton TL Pasko J Kelly G Maynard E Connelly C Orloff S et al. Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis. HPB (Oxford) (2022) 24(3):379–85. doi: 10.1016/j.hpb.2021.06.433
37. Weller A Seyfried T Ahrens N Baier-Kleinhenz L Schlitt H Peschel G et al. Cell salvage during liver transplantation for hepatocellular carcinoma: A retrospective analysis of tumor recurrence following irradiation of the salvaged blood. Transplant Proc (2021) 53(5):1639–44. doi: 10.1016/j.transproceed.2021.03.025
38. Zhai B Sun XY. Controversy over the use of intraoperative blood salvage autotransfusion during liver transplantation for hepatocellular carcinoma patients. World J Gastroenterol (2013) 19(22):3371–4. doi: 10.3748/wjg.v19.i22.3371
39. Hansen E Bechmann V Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective? Transfus Apher Sci (2002) 27(2):153–7. doi: 10.1016/s1473-0502(02)00037-x
40. Yaw PB Sentany M Link WJ Wahle WM GGlover JL. Tumor cells carried through autotransfusion. contraindication to intraoperative blood recovery? JAMA (1975) 231(5):490–1.
41. Massicotte L Thibeault L Beaulieu D Roy JD Roy A. Evaluation of cell salvage autotransfusion utility during liver transplantation. HPB (Oxford) (2007) 9(1):52–7. doi: 10.1080/13651820601090596
42. Phillips SD Maguire D Deshpande R Muiesan P Bowles MJ Rela M et al. A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation. Transplantation (2006) 81(4):536–40. doi: 10.1097/01.tp.0000199318.17013.c5
43. Edelman MJ Potter P Mahaffey KG Frink R Leidich RB. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the RC-400 leukocyte depletion filter. Urology (1996) 47(2):179–81. doi: 10.1016/S0090-4295(99)80411-7
44. Futamura N Nakanishi H Hirose H Nakamura S Tatematsu M. The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg (2005) 71(7):585–90.
45. Frühauf NR Dumpich O Kaudel CP Kasimir-Bauer S Oldhafer KJ. Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Perfusion (2001) 16 Suppl:51–5. doi: 10.1177/026765910101600i107
46. Gwak MS Lee KW Kim SY Lee J Joh JW Kim SJ et al. Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells? Liver Transpl (2005) 11(3):331–5. doi: 10.1002/lt.20346
47. Catling S Williams S Freites O Rees M Davies C Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia (2008) 63(12):1332–8. doi: 10.1111/j.1365-2044.2008.05637.x
48. Esper SA Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus (2011) 9(2):139–47. doi: 10.2450/2011.0081-10
49. Bouras I Mingo O. Should cell salvage be used in oncological surgery? Br J Hosp Med (Lond) (2010) 71(1):57. doi: 10.12968/hmed.2010.71.1.45980
50. Waters JH Yazer M Chen YF Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion (2012) 52(10):2167–73. doi: 10.1111/j.1537-2995.2011.03555.x
51. Wu WW Zhang WY Zhang WH Yang L Deng XQ Ou MC et al. Survival analysis of intraoperative blood salvage for patients with malignancy disease: A PRISMA-compliant systematic review and meta-analysis. Med (Baltimore) (2019) 98(27):e16040. doi: 10.1097/MD.0000000000016040